Abstract

Cycle inhibiting factors (Cifs) are virulence proteins secreted by the type III secretion system of some Gram-negative pathogenic bacteria including Burkholderia pseudomallei. Cif is known to function to deamidate Nedd8, leading to inhibition of Cullin E3 ubiquitin ligases (CRL) and consequently induction of cell cycle arrest. Here we show that Cif can function as a potent activator of MAPK/ERK signaling without significant activation of other signaling pathways downstream of receptor tyrosine kinases. Importantly, we found that the ability of Cif to activate ERK is dependent on its deamidase activity, but independent of Cullin E3 ligase inhibition. This suggests that apart from Nedd8, other cellular targets of Cif-dependent deamidation exist. We provide evidence that the mechanism involved in Cif-mediated ERK activation is dependent on recruitment of the Grb2-SOS1 complex to the plasma membrane. Further investigation revealed that Cif appears to modify the phosphorylation status of SOS1 in a region containing the CDC25-H and proline-rich domains. It is known that prolonged Cullin E3 ligase inhibition leads to cellular apoptosis. Therefore, we hypothesize that ERK activation is an important mechanism to counter the pro-apoptotic effects of Cif. Indeed, we show that Cif dependent ERK activation promotes phosphorylation of the proapoptotic protein Bim, thereby potentially conferring a pro-survival signal. In summary, we identified a novel deamidation-dependent mechanism of action of the B. pseudomallei virulence factor Cif/CHBP to activate MAPK/ERK signaling. Our study demonstrates that bacterial proteins such as Cif can serve as useful molecular tools to uncover novel aspects of mammalian signaling pathways.

Highlights

  • Cycle inhibiting factors (Cifs) are a group of bacterial virulence proteins that are secreted by the Type III Secretion System of some Gram-negative bacterial pathogens including Burkholderia pseudomallei and enteropathogenic and enterohemorrhagic Escherichia coli [1,2]

  • We show that Cifmediated ERK activation is dependent on its deamidase activity but independent of cullin RING E3 ubiquitin ligases (CRLs) inhibition, suggesting that the MAPK/ERK pathway is a novel target of Cif that is different from CRL

  • Our results show that Cif targets the SOS1-Grb2 complex in the MAPK/ERK pathway and modifies the phosphorylation status of the Ras guanine nucleotide exchange factor, SOS1, in the region of SOS1 containing the CDC25-homology and proline-rich domains

Read more

Summary

Introduction

Cycle inhibiting factors (Cifs) are a group of bacterial virulence proteins that are secreted by the Type III Secretion System of some Gram-negative bacterial pathogens including Burkholderia pseudomallei and enteropathogenic and enterohemorrhagic Escherichia coli [1,2]. Upon injection into host cells, Cif is known to inhibit host cell cycle progression at both G1/S and PLOS ONE | DOI:10.1371/journal.pone.0171464. Activation of MAPK/ERK signaling by cycle inhibiting factor. It has been shown that the cell cycle arrest is induced as a result of stabilization of cyclin-dependent kinase inhibitors p21waf1/cip and p27kip (hereafter referred to as p21 and p27) [3,4,5,6]. Cellular concentrations of the cell cycle inhibitors p21 and p27 are normally tightly regulated via ubiquitination by cullin RING E3 ubiquitin ligases (CRLs). Cif has been shown to inhibit CRL function, leading to the accumulation of p21, p27 and numerous other CRL substrates

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call